[144] Nektar Therapeutics SEC Filing

Rhea-AI Filing Summary

Nektar Therapeutics (NKTR) submitted a Form 144 notifying intent to sell 1,500 common shares through Fidelity Brokerage Services (900 Salem Street, Smithfield RI) with an aggregate market value of $45,243.50. The filing reports approximately 19,018,573 shares outstanding and an approximate sale date of 09/02/2025 on the NASDAQ. The shares were originally acquired as restricted stock vesting on 02/15/2018 (655 shares) and 05/15/2018 (845 shares) with payment characterized as compensation. The filing also discloses a prior sale by Howard Robin of 1,573 shares on 08/19/2025 for gross proceeds of $41,826.23. The notice includes the standard Rule 144 representation regarding absence of undisclosed material information.

Positive

• Compliant disclosure: Form 144 includes broker, share counts, market value, and Rule 144 representation
• Clear acquisition history: Shares were acquired via restricted stock vesting in 2018 and labeled as compensation

Negative

• None.

Insights

Financial Analyst

TL;DR: Insignificant insider selling relative to outstanding shares; routine Rule 144 disclosure.

The filing documents a proposed sale of 1,500 common shares valued at $45,243.50, representing roughly 0.0079% of the reported 19,018,573 shares outstanding. Acquisition history shows these shares originated from restricted stock vesting in 2018 and were compensation-related. A recent nearby sale of 1,573 shares on 08/19/2025 for $41,826.23 by Howard Robin is disclosed, indicating ongoing small-volume disposals rather than a large-scale exit. From a financial-signals perspective, the sizes are immaterial and unlikely to affect supply/demand or valuation.

Corporate Governance Expert

TL;DR: Disclosure aligns with compliance expectations; no governance red flags evident from this filing alone.

The Form 144 includes required broker details and the Rule 144 certification about lack of undisclosed material information, and it lists vesting-origin of the shares. The filing shows compliance with procedural requirements for insider dispositions. There is no indication here of unusual timing, concentrated insider sales, or other governance concerns based solely on the reported quantities and dates.

09/02/2025 - 04:42 PM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1500	45243.50	19018573	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2018	Restricted Stock Vesting	Issuer			655	02/15/2018	Compensation
Common	05/15/2018	Restricted Stock Vesting	Issuer			845	05/15/2018	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Howard Robin 455 Mission Bay Boulevard South San Francisco CA 94158	Common	08/19/2025	1573	41826.23

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the NKTR Form 144 report?

The filing notifies a proposed sale of 1,500 common shares valued at $45,243.50, to occur approximately on 09/02/2025 on NASDAQ.

Who is handling the sale reported in the NKTR Form 144?

The broker named is Fidelity Brokerage Services LLC at the address provided in the filing.

How were the shares to be sold acquired according to the filing?

The shares were acquired through restricted stock vesting on 02/15/2018 (655 shares) and 05/15/2018 (845 shares) as compensation.

Has the filer recently sold any NKTR shares?

Yes. The filing discloses a prior sale by Howard Robin of 1,573 shares on 08/19/2025 for gross proceeds of $41,826.23.

How material is the proposed sale relative to NKTR's outstanding shares?

At 1,500 shares versus 19,018,573 outstanding, the proposed sale represents about 0.0079% of outstanding shares, a de minimis amount.